Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.00
Bid: 290.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.448%)
Open: 295.00
High: 295.00
Low: 295.00
Prev. Close: 295.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit

Tue, 05th Mar 2024 20:43

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Beeks Financial Cloud Group PLC - Glasgow-based cloud computing and connectivity provider - Swings to pretax profit of GBP158,000 in the six months to December 31, from a loss of GBP762,000 a year prior. Revenue climbs 25% to GBP13.0 million from GBP10.4 million. Cost of sales increase 31% to GBP8.2 million from GBP6.2 million, while admin expenses decrease 4.2% to GBP4.7 million from GBP4.9 million. Looking ahead, Chief Executive Officer Gordon McArthur says the company is confident as it was underlining "the size of the opportunity we are addressing. Financial markets are still only at the start of the journey to the cloud. With our proven offering and growing tier 1 customer base, which includes some of the largest financial organisations in the world, as well as our increasing profit margins and cash generation, we have never been better placed to seize the opportunity. Our focus for the second half remains the conversion of our significant pipeline."

----------

dotdigital Group PLC - London-based online marketing company - Pretax profit edges down negligibly to GBP7.38 million in the six months to December 31, from GBP7.42 million a year prior. Revenue however grows 15% to GBP38.7 million from GBP33.8 million. Cost of sales increase 14% to GBP8.0 million from GBP7.1 million. Administrative expenses increase 16% to GBP22.4 million from GBP19.2 million. Looking ahead, the company says it enters the second financial half "with good trading momentum and the ability to attract higher value deals, underpinned by continuous product enhancements to drive cross- and up-sells from the existing base." It adds: "We remain confident in the group's ability to continue to execute against its stated strategy and meet market expectations."

----------

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Confirms 2023 results it had announced in January. Further, expects core revenue growth of between none and 5% in 2024 compared to 2023. Expects strategic platform license programme-related revenue of around USD3 million for the year, down sharply from USD11.4 million in 2023. CEO Maher Masoud says: "As we continue to expand our SPL portfolio this year, we remain confident in our ability to support our current and prospective clients as new waves of next-generation cell therapies come to market."

----------

Origin Enterprises PLC - Dublin-based agronomy services firm - Pretax profit dives 96% to EUR5.3 million in the six months to January 31, from EUR13.3 million a year prior. Revenue drops 28% to EUR854.9 million from EUR1.18 billion. Notes an expected correction in global feed and fertiliser raw materials regarding decline in revenue. Despite the results, maintains interim dividend at 3.15 euro cents per share. Looking ahead, says on-farm sentiment remains cautious as growers shift towards spring planting and seek to optimise yields from a reduced autumn/winter planted area. Further, expects financial 2024 earnings per share between 44 and 49 euro cents, reflecting adverse weather. This compares to EPS of 45.24c Origin Enterprises had reported for financial 2023.

----------

Thor Energy PLC - US and Australia-focused mineral exploration company - Pretax loss widens to GBP2.3 million in the six months to December 31, from GBP8,000 a year prior. Posts no revenue. Notes costs regarding a write off of exploration assets of around GBP1.9 million in the most recent half-year, compared to no such cost a year prior. Managing Director Nicole Warland says: "After ending the year with consistent high-grade uranium results from our 2023 drilling program, we are optimistic about our 2024 drilling programs as we continue to strategically position our portfolio towards advancing our 'green energy' projects in the US." She adds: "With a strong pipeline of news flow expected for the coming months and project milestones across the portfolio, we anticipate 2024 to provide significant progress in our key assets and we will provide further updates in due course."

----------

Time Out Group PLC - Global media and hospitality business - Pretax loss narrows 63% to GBP4.6 million in the six months to December 31, from GBP12.5 million a year prior. Revenue falls 2.4% to GBP52.5 million from GBP53.8 million. However, like-for-like revenue in constant currency climbs 6.9% to GBP54.9 million from GBP51.4 million. Time Out says it has made "significant" further progress in driving profitability and operational cash generation. It says it has several potential growth avenues, citing collaboration with leading landlords and developers.

----------

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
30 Apr 2024 14:38

UK earnings, trading statements calendar - next 7 days

Wednesday 1 May 
Anexo Group PLCFull Year Results
Cambridge Cognition Holdings PLCFull Year Results
Computacenter PLCTrading Statement
Georgia Capital PLCQ1 Results
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
Thursday 2 May 
Endeavour Mining PLCQ1 Results
First Tin PLCTrading Statement
Hiscox LtdTrading Statement
International Personal Finance PLCTrading Statement
Kerry Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
Melrose Industries PLCTrading Statement
NAHL Group PLCFull Year Results
Reach PLCTrading Statement
Shell PLCQ1 Results
Smiths News PLCHalf Year Results
Smurfit Kappa Group PLCTrading Statement
Spectris PLCTrading Statement
Standard Chartered PLCQ1 Results
TI Fluid Systems PLCQ1 Results
Friday 3 May 
InterContinental Hotels Group PLCTrading Statement
Mondi PLCTrading Statement
Trainline PLCFull Year Results
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Arecor Therapeutics PLCFull Year Results
BP PLCQ1 Results
Ebiquity PLCFull Year Results
IWG PLCTrading Statement
Kosmos Energy LtdQ1 Results
MaxCyte IncQ1 Results
Trident Royalties PLCTrading Statement
Vaalco Energy IncQ1 Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Apr 2024 15:19

TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Mar 2024 12:04

MaxCyte reports strong fourth quarter as full-year revenues fall

(Sharecast News) - Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15.7m on Wednesday, up 26% on the same period in 2022.

Read more
13 Mar 2024 11:54

IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%

MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Net loss widens to USD37.9 million in 2023 from USD23.6 million in 2022, as revenue declines by 6.7% to USD41.3 million from 44.3 million. Core business revenue falls by 25% to USD29.8 million from USD39.6 million, but strategic platform license programme-related revenue more than doubles to USD11.5 million from USD4.6 million. In the fourth quarter alone, revenue is USD15.7 million, up 26% from USD12.4 million a year before, as core business revenue falls by 32% but SPL revenue more than quadruples.

Read more
5 Mar 2024 16:06

UK earnings, trading statements calendar - next 7 days

Wednesday 6 March 
Breedon Group PLCFull Year Results
Capita PLCFull Year Results
ConvaTec Group PLCFull Year Results
DS Smith PLCTrading Statement
Galliford Try Holdings PLCHalf Year Results
Greencoat Renewables PLCFull Year Results
Ibstock PLCFull Year Results
Lancashire Holdings LtdFull Year Results
Legal & General Group PLCFull Year Results
Netcall PLCHalf Year Results
Nexxen International LtdFull Year Results
Nichols PLCFull Year Results
Quilter PLCFull Year Results
Rathbones Group PLCFull Year Results
Ricardo PLCFull Year Results
Spirent Communications PLCFull Year Results
TClarke PLCFull Year Results
Tullow Oil PLCFull Year Results
CLS Holdings PLCFull Year Results
Thursday 7 March 
Admiral Group PLCFull Year Results
Aviva PLCFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Coats Group PLCFull Year Results
Darktrace PLCHalf Year Results
Elementis PLCFull Year Results
Entain PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Harbour Energy PLCFull Year Results
ITV PLCFull Year Results
Kier Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Nexus Infrastructure PLCFull Year Results
PageGroup PLCFull Year Results
Physiomics PLCHalf Year Results
Rentokil Initial PLCFull Year Results
Robert Walters PLCFull Year Results
Spirax-Sarco Engineering PLCFull Year Results
TT Electronics PLCFull Year Results
Tyman PLCFull Year Results
Friday 8 March 
Informa PLCFull Year Results
Just Group PLCFull Year Results
LMS Capital PLCFull Year Results
Stelrad Group PLCFull Year Results
Monday 11 March 
HgCapital Trust PLCFull Year Results
Mincon Group PLCFull Year Results
MTI Wireless Edge LtdFull Year Results
Tuesday 12 March 
BATM Advanced Communications LtdFull Year Results
Costain Group PLCFull Year Results
Domino's Pizza Group PLCFull Year Results
Fonix Mobile PLCHalf Year Results
Foresight Solar Fund LtdFull Year Results
Genuit PLCFull Year Results
H&T Group PLCFull Year Results
Hill & Smith PLCFull Year Results
MaxCyte IncFull Year Results
Persimmon PLCFull Year Results
Synthomer PLCFull Year Results
Target Healthcare REIT PLCHalf Year Results
TI Fluid Systems PLCFull Year Results
TP ICAP Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
5 Mar 2024 13:01

MaxCyte flags lower 2023 revenue, flat 2024 growth

(Sharecast News) - Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41.1m and $41.3m, down from $44.3m in 2022.

Read more
30 Jan 2024 13:58

IN BRIEF: MaxCyte signs licencing deal with cell therapy company Wugen

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Signs strategic platform licence with Wugen Inc, a US-based clinical-stage biotech company developing off-the-shelf cell therapies for the treatment of hematological and solid cancer tumour malignancies. Wugen's lead program is evaluating WU-CART-007, a cell therapy for the treatment of relapsed or refractory T-cell acute lymphoblastic leukaemia. Under the terms of the agreement, Wugen gains non-exclusive clinical and commercial rights to use MaxCyte's unique Flow electroporation technology and its trademarked ExPERT research platform. In exchange, MaxCyte will receive annual licence fees and programme-related revenue, although precise transaction details were not provided.

Read more
29 Jan 2024 17:56

IN BRIEF: MaxCyte chief scientific officer leaves firm

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Announces departure of Cenk Sumen as chief scientific officer, but he will remain on advisory board.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
9 Jan 2024 12:18

MaxCyte's strategic platform licences redeem otherwise modest results

(Alliance News) - MaxCyte Inc on Tuesday said that promising returns from its strategic platform licence program had bolstered its quarterly revenue expectations.

Read more
9 Jan 2024 08:55

MaxCyte flags uptick in total fourth-quarter revenue

(Sharecast News) - Cell engineering company MaxCyte said on Tuesday that total fourth-quarter revenue was expected to be between $15.5m and $15.7m.

Read more
3 Jan 2024 14:04

MaxCyte teams with Singapore-based Lion to support TCR-T cell work

(Alliance News) - MaxCyte Inc on Wednesday said it had signed a strategic platform licence with Lion TCR to promote the latter's T cell receptor-T cell pipeline.

Read more
2 Jan 2024 11:25

Maher Masoud starts as MaxCyte president, CEO

(Sharecast News) - MaxCyte confirmed the appointment of Maher Masoud as its new president and chief executive officer on Tuesday, effective from 1 January.

Read more
12 Dec 2023 15:56

TRADING UPDATES: Technology Minerals identifies lithium at Knockeen

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.